ISSCR News
The ISSCR Announces the Election of New Officers and Members of the Board of Directors
Skokie, IL – The International Society for Stem Cell Research (ISSCR) is pleased to announce the results of its 2022 election. Valentina Greco, PhD, Carolyn Walch Slayman Professor and Vice-chair of Diversity, Equity, and Inclusion in the Genetics Department, Yale School of Medicine, USA will become the next Vice President. Clive Svendsen, PhD, Kerry and Simone Vickar Family Foundation Distinguished Chair in Regenerative Medicine and Executive Director of the Board of Governors Regenerative Medicine Institute at Cedars-Sinai Medical Center in Los Angeles, USA was elected Treasurer.
The Future Is Now
We’ve seen some extraordinary stem cell advances reaching the clinic. A recent clinical trial could have a significant impact on patients with Type 1 diabetes. Advances in cell therapy for the treatment of Parkinson’s disease, and a stem cell-derived model that has enabled researchers to identify drug candidates that may slow dry age-related macular degeneration (AMD). These are only a few of the potential ways stem cell science is positioned to make significant impact on the treatment of devastating diseases.
Member Spotlight: Ujang Purnama
“What I value most about being an ISSCR member is the annual meeting. I really like interacting and having conversations with people in the stem cell community to discuss my work”.
Boosting Function and Survival of Stem Cell-derived Pancreatic Cells by Genetic Engineering
Recent advances in the transplantation of stem cell-derived insulin-producing beta cells (SC-beta cells) to treat type 1 diabetes (T1D) has generated considerable interest and excitement. A major obstacle to the long-term survival and functioning of SC-beta cells is their vulnerability to stress or attacks from the immune system, which can ultimately lead to malfunction or death of the cells. A recent study published in the journal Stem Cell Reports has identified new ways to potentially enhance the SC-beta cell survivability through genetic manipulation of the cells.
The ISSCR Comments on Draft Guidance from FDA - Real-World Data: Assessing Registries to Support Regulatory Decision-Making for Drug and Biological Products
The ISSCR shared comments on draft guidance from the FDA's Center for Biologics Evaluation and Research (CBER) (Docket No. FDA2021-D-1146) Real-World Data: Assessing Registries to Support Regulatory Decision Making for Drug and Biological Products.
Receive ISSCR Press Releases
Sign up be a part of ISSCR’s media list. Media Contact: Kym Kilbourne, Director of Media and Strategic Communications
Subscribe to ISSCR News.
Each month, ISSCR delivers scientific, policy, and community to your inbox .